Edwards Lifesciences Corporation
Stock Details
Is it expensive?
Trailing P/E Ratio
46.37
Forward P/E Ratio
25.49
PEG Ratio
5.66
24.39
Price-to-Sales (TTM)
7.84
4.79
17.90
Market Cap
49.39B
46.42B
Is it profitable?
Net Profit Margin (TTM)
17.39%
Gross Profit Margin
78.01%
Diluted EPS (TTM)
1.85
10.46%
6.30B
Is it growing?
16.70%
6.30%
Is it risky?
0.87
6.81
4.42
702.90M
Who owns it?
94.11%
0.18%
2.08%
577.00M
573.97M
Does it pay?
0.00%
0.00%
--
--
How much cash?
3.67B
1.36B
902.14M
6.38
- Price
- 85.78
- Percent Change
- +2.58 (3.10%)
- Previous Close
- 83.20
- Open
- 83.77
- Low
- 83.12
- High
- 86.03
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$85.78
From 52W Low
+18.64%
From 52W High
-2.40%
Today
+3.10%
1Y Change
+12.54%
6M
$86.75
3M
$85.90
1M
$83.46
Today
$85.78
From 52W Low
+18.64%
From 52W High
-2.40%
Today
+3.10%
1Y Change
+12.54%
6M
$86.75
3M
$85.90
1M
$83.46
Today
$85.78
Expensive
within its 1-year price range
$85.78
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+2.8%
3M
-0.1%
6M
-1.1%
1Y
+12.5%
Rate of Change (ROC)
Accelerating
Price is rising 9.3x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Average
Volume is in line with the 90-day average. No unusual activity detected. Price moves on average volume carry less confirmation. As reflected in the Relative Volume (RVOL) below.
- Name
- Edwards Lifesciences Corporation
- Founded
- 1958
- CEO
- Bernard J. Zovighian
- Employees
- 16,000
- Fiscal Year End
- Dec 31, 2025
- Address
One Edwards Way
Irvine
California
92614
United States
- GICS Classification
- Health Care›Health Care Equipment & Services›Health Care Equipment & Supplies
- Website
- www.edwards.com
Indicators
Operating Cash Flow
1.36B
Net Income
1.08B
Real Earnings
1.26
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
S&P 500Index S&P 500 - SPX |
Indicators
Operating Cash Flow
1.36B
Net Income
1.08B
Real Earnings
1.26
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
46.37
Forward P/E Ratio
25.49
PEG Ratio
5.66
24.39
Price-to-Sales (TTM)
7.84
4.79
17.90
Market Cap
49.39B
46.42B
Is it profitable?
Net Profit Margin (TTM)
17.39%
Gross Profit Margin
78.01%
Diluted EPS (TTM)
1.85
10.46%
6.30B
Is it growing?
16.70%
6.30%
Is it risky?
0.87
6.81
4.42
702.90M
Who owns it?
94.11%
0.18%
2.08%
577.00M
573.97M
Does it pay?
0.00%
0.00%
--
--
How much cash?
3.67B
1.36B
902.14M
6.38
- Price
- 85.78
- Percent Change
- +2.58 (3.10%)
- Previous Close
- 83.20
- Open
- 83.77
- Low
- 83.12
- High
- 86.03
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$85.78
From 52W Low
+18.64%
From 52W High
-2.40%
Today
+3.10%
1Y Change
+12.54%
6M
$86.75
3M
$85.90
1M
$83.46
Today
$85.78
From 52W Low
+18.64%
From 52W High
-2.40%
Today
+3.10%
1Y Change
+12.54%
6M
$86.75
3M
$85.90
1M
$83.46
Today
$85.78
Expensive
within its 1-year price range
$85.78
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+2.8%
3M
-0.1%
6M
-1.1%
1Y
+12.5%
Rate of Change (ROC)
Accelerating
Price is rising 9.3x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Average
Volume is in line with the 90-day average. No unusual activity detected. Price moves on average volume carry less confirmation. As reflected in the Relative Volume (RVOL) below.
- Name
- Edwards Lifesciences Corporation
- Founded
- 1958
- CEO
- Bernard J. Zovighian
- Employees
- 16,000
- Fiscal Year End
- Dec 31, 2025
- Address
One Edwards Way
Irvine
California
92614
United States
- GICS Classification
- Health Care›Health Care Equipment & Services›Health Care Equipment & Supplies
- Website
- www.edwards.com
Related Heatmaps
S&P 500Index S&P 500 - SPX |